Aspireo Reports Data in Further Phase Ib Study
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Critical Pharmaceuticals today announces that it has successfully completed a second clinical study on its CP024 growth…
Aspireo Pharmaceuticals Limited, ("Aspireo") an Israeli biopharmaceutical company, focused on the development of Somatop…
Q Chip Ltd and ARTES Biotechnology GmbH announce that they have signed a Collaborative Agreement to explore the co-devel…